Amplifon S.p.A Operating Income 2019-2024 | AMFPF
Amplifon S.p.A annual/quarterly operating income history and growth rate from 2019 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Amplifon S.p.A operating income for the quarter ending September 30, 2024 was $0M, a 100% decline year-over-year.
- Amplifon S.p.A operating income for the twelve months ending September 30, 2024 was $0.186B, a 66.68% decline year-over-year.
- Amplifon S.p.A annual operating income for 2024 was $0.278B, a 0.94% decline from 2023.
- Amplifon S.p.A annual operating income for 2023 was $0.281B, a 4.45% decline from 2022.
- Amplifon S.p.A annual operating income for 2022 was $0.294B, a 0.88% increase from 2021.
| Amplifon S.p.A Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $278 |
| 2023 | $281 |
| 2022 | $294 |
| 2021 | $291 |
| 2020 | $192 |
| 2019 | $198 |
| 2018 | $181 |
| Amplifon S.p.A Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-03-31 | $70 |
| 2023-03-31 | $57 |
| 2022-03-31 | $59 |
| 2021-03-31 | $50 |
| 2020-03-31 | $16 |
| 2019-03-31 | $37 |
| 2018-12-31 | $456 |
| 2018-09-30 | $353 |
| 2018-06-30 | $430 |
| 2018-03-31 | $380 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.378B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.923B | 27.18 |
| CVS Health (CVS) | United States | $84.250B | 10.47 |
| Elevance Health (ELV) | United States | $79.134B | 10.21 |
| Cencora (COR) | United States | $56.436B | 19.63 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.062B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.762B | 17.65 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.704B | 0.00 |
| Solventum (SOLV) | United States | $13.538B | 14.33 |
| CochLear (CHEOY) | Australia | $12.960B | 0.00 |
| ICON (ICLR) | Ireland | $12.180B | 11.32 |
| Revvity (RVTY) | United States | $11.893B | 20.47 |
| Viatris (VTRS) | United States | $10.962B | 3.77 |
| Avantor (AVTR) | United States | $9.465B | 13.75 |
| Medpace Holdings (MEDP) | United States | $9.371B | 24.89 |
| HealthEquity (HQY) | United States | $8.758B | 38.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.535B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.735B | 15.16 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.798B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.867B | 28.67 |
| BrightSpring Health Services (BTSG) | United States | $3.868B | 35.48 |
| Sotera Health (SHC) | United States | $3.304B | 18.77 |
| Surgery Partners (SGRY) | United States | $2.822B | 36.70 |
| Alignment Healthcare (ALHC) | United States | $2.693B | 0.00 |
| Concentras Parent (CON) | United States | $2.647B | 15.30 |
| Organon (OGN) | United States | $2.639B | 2.80 |
| GeneDx Holdings (WGS) | United States | $2.562B | 98.67 |
| PACS (PACS) | United States | $1.987B | 0.00 |
| Ardent Health (ARDT) | United States | $1.920B | 8.18 |
| Progyny (PGNY) | United States | $1.821B | 40.08 |
| GoodRx Holdings (GDRX) | United States | $1.805B | 36.11 |
| Premier (PINC) | United States | $1.789B | 13.58 |
| Teladoc Health (TDOC) | United States | $1.465B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.283B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.184B | 9.01 |
| CareDx (CDNA) | United States | $1.085B | 16.95 |
| Agilon Health (AGL) | United States | $0.989B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.843B | 7.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.679B | 10.28 |
| Embecta (EMBC) | United States | $0.599B | 4.04 |
| LifeMD (LFMD) | United States | $0.588B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.560B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| Omada Health (OMDA) | $0.466B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.463B | 0.00 |
| Enhabit (EHAB) | United States | $0.390B | 32.12 |
| So-Young (SY) | China | $0.338B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.316B | 0.00 |
| Beauty Health (SKIN) | United States | $0.266B | 0.00 |
| Oncology Institute (TOI) | United States | $0.218B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 26.17 |
| Pheton Holdings (PTHL) | China | $0.121B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.079B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.027B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |